Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 2,055,222 shares at $15.33 ($31.7M) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market sale of $31.7M CPRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.33 | 80,765 | $1.2M | 3.9% |
| 2 | $15.33 | 80,765 | $1.2M | 3.9% |
| 3 | $15.41 | 946,846 | $14.6M | 46.1% |
| 4 | $15.41 | 946,846 | $14.6M | 46.1% |
| Total | $15.40 avg | 2,055,222 | $31.7M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |